Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Current Liabilities (2020 - 2025)

Biofrontera (BFRI) has 6 years of Total Current Liabilities data on record, last reported at $12.6 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 13.79% year-over-year to $12.6 million; the TTM value through Sep 2025 reached $12.6 million, up 13.79%, while the annual FY2024 figure was $12.0 million, 33.54% down from the prior year.
  • Total Current Liabilities reached $12.6 million in Q3 2025 per BFRI's latest filing, down from $19.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $29.1 million in Q3 2023 and bottomed at $9.3 million in Q2 2024.
  • Average Total Current Liabilities over 5 years is $15.5 million, with a median of $13.9 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: soared 213.03% in 2021, then tumbled 62.12% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $13.8 million in 2021, then soared by 51.01% to $20.9 million in 2022, then dropped by 13.43% to $18.1 million in 2023, then tumbled by 33.54% to $12.0 million in 2024, then rose by 4.43% to $12.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $12.6 million in Q3 2025, $19.7 million in Q2 2025, and $11.0 million in Q1 2025.